Description
Retatrutide is a synthetic triple-agonist peptide targeting the GLP-1, GIP, and glucagon receptors, supplied as a research-grade, lyophilized reagent for laboratory and in-vitro research into metabolic regulation and energy-homeostasis pathways. Every vial is characterized by independent third-party testing for identity and purity, packaged under controlled conditions, and shipped from North America with a lot-specific certificate of analysis available on request. Intended exclusively for use by qualified researchers and laboratory personnel. For research use only, not for human consumption, not for injection, and not for therapeutic use. Classification, handling, and suitability for any specific application are the responsibility of the purchasing institution.

Reviews
There are no reviews yet.